Dose and drug changes in chronic lymphocytic leukemia cell response in�vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors

Author:

Kubczak Małgorzata1,Szustka Aleksandra1,Błoński Jerzy2,Guck� Tomaš3,Misiewicz Małgorzata2,Krystof Vladmir4,Robak Paweł5,Rogalińska Małgorzata1

Affiliation:

1. Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 90‑236 Lodz, Poland

2. Department of Hematology, Medical University of Lodz, 93‑510 Lodz, Poland

3. Department of Chemical Biology and Genetics, Centre of the Region Han� for Biotechnological and Agricultural Research, Faculty of Science, Palack� University, 78371 Olomouc, Czech Republic

4. Laboratory of Growth Regulators, Faculty of Science, Palack� University and Institute of Experimental Botany AS CR, 78371 Olomouc, Czech Republic

5. Department of Experimental Hematology, Medical University of Lodz, 93‑510 Lodz, Poland

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Indirubin In Vitro Apoptotic Effect on Chronic Lymphocytic Leukemia Cells;Middle East Journal of Rehabilitation and Health Studies;2024-05-29

2. Molecular Targets of Natural Compounds with Anti-Cancer Properties;International Journal of Molecular Sciences;2021-12-20

3. New Perspectives in Personalization of Therapy for Hematological Cancers;Methods in Molecular Medicine;2021-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3